Cedars Sinai
Videos
Cedars Sinai
Management of Toxicity and Dose Modification Associated With Cabozantinib in HCC
FEATURING
Jun Gong
- 2 views
- April 19, 2024
Cedars Sinai
Unmet Need in HR+/HER2- mBC: Resistance to 1L CDK4/6i and ET
FEATURING
Yuan Yuan
- 86 views
- April 18, 2024
- 2
Cedars Sinai
Management of Toxicities Associated With Targeted Agents in Stage 4 HR+/HER2- BC
FEATURING
Yuan Yuan
- 33 views
- April 18, 2024
Cedars Sinai
2024 Updates in eBC Treatment for Postmenopausal HR+/HER2- Patients
FEATURING
Yuan Yuan
- 24 views
- April 18, 2024
Cedars Sinai
Year in Review: EMBARK Study and the Evolving Role of Intensified ADT for Non-Metastatic CSPC
FEATURING
Stephen Freedland
- 249 views
- January 12, 2024
- 2
Cedars Sinai
MRD in ALL: Testing Methods and How to Respond to Presence or Absence of MRD
FEATURING
Noah Merin
- 114 views
- May 11, 2023
- 5
Cedars Sinai
Optimizing Treatment Sequencing for Patients With Advanced Gastric Cancer: What Oncologists Need to Know
FEATURING
Jun Gong
- 141 views
- April 25, 2023
Cedars Sinai
Goals of Care and QoL in Patients With Metastatic Cervical Cancer: What Oncologists Should Discuss With Patients
FEATURING
Bobbie J. Rimel
- 118 views
- November 30, 2022
Cedars Sinai
ASCO 2022: Identification of Transcriptional Changes With MammaPrint and BluePrint in EBC After Neoadjuvant Chemo
FEATURING
Alice Chung
- 203 views
- June 7, 2022
- 1
Cedars Sinai
PD-L1 CPS As a Biomarker for Patient Selection for Immunotherapy in Advanced Esophagogastric Adenocarcinoma
FEATURING
Jun Gong
- 252 views
- May 13, 2022
- 2
Cedars Sinai
Progress and Updates in Neoadjuvant Strategies for Melanoma
FEATURING
Mark Faries
- 146 views
- October 6, 2021
Cedars Sinai
Pioneers in Medicine With Dr. Gewertz: Making Personalized Medicine Possible for IBD Patients
FEATURING
Stephan Targan,
Bruce Gewertz
- 100 views
- September 3, 2021